These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of acute stroke]. Sztajzel R; Reichhart M; Michel P; Bogousslavsky J Rev Med Suisse; 2005 May; 1(18):1192-4, 1197-200. PubMed ID: 15977707 [TBL] [Abstract][Full Text] [Related]
4. GP IIb/IIIa blockade during peripheral artery interventions. Tepe G; Wiskirchen J; Pereira P; Claussen CD; Miller S; Duda SH Cardiovasc Intervent Radiol; 2008; 31(1):8-13. PubMed ID: 17479207 [TBL] [Abstract][Full Text] [Related]
5. Use of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. Fernandez JS; Sadaniantz A Med Health R I; 2001 Feb; 84(2):37-43. PubMed ID: 11272658 [No Abstract] [Full Text] [Related]
6. Reperfusion synergism: will it be both sustained and safe? Armstrong PW Eur Heart J; 2000 Dec; 21(23):1913-6. PubMed ID: 11071795 [No Abstract] [Full Text] [Related]
17. Antithrombotic treatment of NSTEMI/UAP. The interaction with PCI. Otterstad JE; Brosstad F Scand Cardiovasc J; 2004 Mar; 38(1):9-15. PubMed ID: 15204241 [No Abstract] [Full Text] [Related]
18. The expanding role of antiplatelet agents in coronary artery disease. A current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines. Hostetter JC; Bhatt DL Minerva Cardioangiol; 2003 Oct; 51(5):531-46. PubMed ID: 14551522 [TBL] [Abstract][Full Text] [Related]